Ameritas Investment Partners’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125K Buy
1,815
+246
+16% +$14K ﹤0.01% 1688
2026
Q1
$101K Hold
1,569
– – ﹤0.01% 1697
2025
Q4
$204K Hold
1,569
– – 0.01% 1242
2025
Q3
$169K Sell
1,569
-348
-18% -$37.9K 0.01% 1329
2025
Q2
$177K Buy
1,917
+726
+61% +$57K 0.01% 1373
2025
Q1
$105K Hold
1,191
– – ﹤0.01% 1661
2024
Q4
$91.5K Hold
1,191
– – ﹤0.01% 1831
2024
Q3
$50.5K Hold
1,191
– – ﹤0.01% 2187
2024
Q2
$31.1K Buy
+1,191
New +$22.6K ﹤0.01% 2398
2023
Q2
– Sell
-359
Closed -$4.33K – 3224
2023
Q1
$4.33K Hold
359
– – ﹤0.01% 2886
2022
Q4
$4.71K Hold
359
– – ﹤0.01% 2929
2022
Q3
$10K Hold
359
– – ﹤0.01% 2808
2022
Q2
$14K Buy
+359
New +$24.4K ﹤0.01% 2727

Other funds holding WGS

Ameritas Investment Partners's WGS Position: Q2 2026 in Review

Ameritas Investment Partners increased its GeneDx Holdings (WGS) stake by 16% in Q2 2026, buying an estimated $14K and bringing the position to 1,815 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

Ameritas Investment Partners first reported a position in WGS in Q2 2022 and has held it in 13 quarters since. The position peaked at $204K in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Ameritas Investment Partners held 1,815 shares of GeneDx Holdings worth $125K as of Q2 2026.
  • Ameritas Investment Partners bought 246 GeneDx Holdings shares in Q2 2026, an estimated $14K.
  • GeneDx Holdings made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1688 holding.
  • Ameritas Investment Partners first reported a position in GeneDx Holdings in Q2 2022 and has held it in 13 quarters since.
  • Ameritas Investment Partners's GeneDx Holdings position peaked at $204K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.